Accent Therapeutics
Founded
2017
2017
Geography
United States of America based
United States of America based
Funding
$40 M
$40 M
Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology encompasses post-transcriptional chemical modifications of RNA that provide cells with a unique mechanism for regulating proteins critical for cellular growth and differentiation. By targeting cancer-linked RNA-modifying proteins (RMPs) with precision therapies, they aim to translate extraordinary science into life-changing therapies for patients.
Technologies
RNA-focused StartupsR&D Platform
Pipelines
No pipelines published yet
Products
Services
No services posted yet